Association of Plasma Metabolites and Cardiac Mitochondrial Function with Heart Failure Progression
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15215 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Vandana Revathi Venkateswaran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Individualized and Genomic Medicine Research (CIGMA), Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Heart Failure, Mitochondria, Heart, Ventricular Remodeling, Stroke Volume. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMHD NIH HHS, NHLBI NIH HHS, NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Plasma metabolites are prognostic in heart failure with reduced ejection fraction (HFrEF), with citric acid cycle metabolites linked to ejection fraction (EF) changes. We investigated these mechanisms in a canine chronic HFrEF model. We tested associations between changes in plasma metabolites, left ventricular (LV) end-diastolic volume and cardiomyocyte mitochondrial function.
Methods
Eighteen dogs underwent microembolization to induce moderate HFrEF (target LVEF 35%–40%). Plasma metabolites, LV size and mitochondrial function were assessed over 12 months.
Results
Plasma metabolite heatmap showed acylcarnitine changes, with early alterations in organic acids and amino acids predicting later adverse LV remodelling. Using either baseline or change over time, 13 metabolites correlated with 12 month LV enlargement. This is mostly often at 3 months (11 of 13), notably C18:2 (r = −0.58, P = 0.003) and cardiac anaplerotic substrates like glutamine (r = −0.52, P = 0.009) and 3-HBA (r = −0.43, P = 0.035). Impaired cardiomyocyte mitochondrial function correlated with LV enlargement (max ATP synthesis 12.7 vs. 19.9 nmol/min/mg, P = 0.0036; ADP-stimulated respiration 224 vs. 308 nAtom O/min/mg protein; P = 0.0064). Plasma metabolites correlated with mitochondrial parameters at 12 month, particularly with MAX ATP: malate (r = −0.75, P < 0.001), fumarate (r = −0.6, P = 0.008) and glutamine (r = 0.51, P = 0.031).
Conclusions
In canine HFrEF, plasma acylcarnitines, citric acid cycle or anaplerotic metabolites predicted adverse LV remodelling. LV enlargement correlated with reduced cardiomyocyte mitochondrial function, which in turn was also associated with increased citric acid cycle metabolites. Together, these data suggest impaired cardiac energetic function drives plasma metabolite associations in HFrEF progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Individualized and Genomic Medicine Research (CIGMA), Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
- Department of Public Health Sciences, Henry Ford Hospital, Detroit, Michigan, USA.
- AdventHealth Translational Research Institute, Orlando, Florida, USA.
- Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
- Division of Cardiovascular Medicine, Department of Medicine, Henry Ford Hospital, Henry Ford Health, Detroit, Michigan, USA.
ORCID-Profile: Vandana Revathi Venkateswaran
Förderung
- NIMHD NIH HHS
- NHLBI NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Venkateswaran, V. R., She, R., Gardell, S. J., Luzum, J. A., Gupta, R., Zhang, K., Williams, L. K., Sabbah, H. N., & Lanfear, D. E. (2025). Association of Plasma Metabolites and Cardiac Mitochondrial Function with Heart Failure Progression. ESC Heart Failure. https://doi.org/10.1002/ehf2.15215
Vancouver
Venkateswaran VR, She R, Gardell SJ, Luzum JA, Gupta R, Zhang K, et al. Association of Plasma Metabolites and Cardiac Mitochondrial Function with Heart Failure Progression. ESC Heart Failure. 2025. doi:10.1002/ehf2.15215
BibTeX
@article{Venkateswaran2025,
author = {Venkateswaran, Vandana Revathi and She, Ruicong and Gardell, Stephen J and Luzum, Jasmine A and Gupta, Ramesh and Zhang, Kefei and Williams, L Keoki and Sabbah, Hani N and Lanfear, David E},
title = {Association of Plasma Metabolites and Cardiac Mitochondrial Function with Heart Failure Progression},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15215}
}
EUVIMED